Use of 64CuCl2 PET/CT Imaging in the selection of patients with prostate cancer in biochemical relapse after prostatectomy, to be successfully treated with salvage radiotherapy on the prostatic bed.
This research is investigating a special type of scan, called a 64CuCl2 PET/CT, for men who have had surgery for prostate cancer, but whose cancer markers (PSA levels) have started to rise again. This rise suggests the cancer might be coming back, usually in the area where the prostate used to be. The study wants to see if this new scan can accurately show if there's any remaining cancer in that area. This information could help doctors choose the best treatment, specifically salvage radiotherapy, which is a second course of radiation to the area. The main goal is to understand if the scan can predict which patients will respond well to this radiotherapy.
At a glance
What is this study about?
This study is looking into a new way to help doctors treat prostate cancer. Sometimes, after men have their prostate gland removed by surgery (called a prostatectomy) because of cancer, the levels of a substance in their blood called PSA (Prostate-Specific Antigen) can start to go up again. This rise in PSA can mean that the cancer might be coming back, often in the area where the prostate used to be – this is called the prostatic bed.
When this happens, doctors sometimes suggest a treatment called 'salvage radiotherapy'. This is a course of radiation treatment aimed at the area where the prostate used to be, to try and get rid of any cancer cells that are still there. However, it's not always clear who will benefit most from this radiotherapy. This study is testing a special type of scan, called a 64CuCl2 PET/CT scan. This scan uses a small amount of a harmless radioactive substance that can help highlight any cancer cells.
The main aim of this study is to see if what the 64CuCl2 PET/CT scan shows in the prostatic bed can predict whether a patient will respond well to salvage radiotherapy. If the scan can accurately show if there's cancer present in that area, it could help doctors make more informed decisions about who should receive this treatment, potentially avoiding unnecessary radiotherapy for people who won't benefit, and ensuring those who will are offered it.
Key takeaways
- This study evaluates a special scan (64CuCl2 PET/CT) for prostate cancer.
- It's for men whose PSA levels are rising after prostate surgery.
- The scan aims to predict who will benefit from further radiation treatment.
- It could help doctors make more targeted treatment decisions.
- Participation involves scans and careful monitoring of your health.
Who may be eligible?
To be part of this study, you need to be an adult male, at least 18 years old. This research is specifically for men who have previously had surgery to remove their prostate gland because of prostate cancer, but whose blood tests now show that their PSA levels are starting to increase again. This rise in PSA suggests that the cancer might be returning.
It's important to note that joining any clinical study has specific requirements. The research team will review your medical history and current health to make sure this study is suitable for you. They will explain all the details and answer any questions you have.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you male?
- Are you 18 years old or older?
- Have you had surgery to remove your prostate due to cancer?
- Are your PSA levels currently rising after that surgery?
What does participation involve?
Taking part in this study would involve having a 64CuCl2 PET/CT scan. This scan uses a special, harmless radioactive liquid that is given to you as an injection, and then pictures are taken of your body. The study aims to see if what this scan shows can help doctors choose the best treatment for you.
Researchers will also be closely monitoring your PSA levels both before and after any treatment you receive. This helps them understand how well the treatments are working. You would also have regular check-ups, and the medical team would carefully record any new symptoms or effects you might experience during the study. The total duration of your participation would depend on your individual treatment plan and follow-up schedule.
Potential risks and benefits
Locations (1)
- —UnverifiedItaly
Common questions
What is PSA?
PSA stands for Prostate-Specific Antigen. It's a protein made by the prostate gland. Higher PSA levels can sometimes suggest prostate cancer or other prostate problems.
What is a prostatectomy?
A prostatectomy is a surgery to completely remove the prostate gland, usually done to treat prostate cancer.
What is 'salvage radiotherapy'?
This is a type of radiation treatment given after initial treatment (like surgery) to try and clear up any remaining cancer cells, often in the area where the prostate used to be.
What is a 64CuCl2 PET/CT scan?
It's a special type of medical scan that uses a small amount of a harmless radioactive substance (64CuCl2) to create detailed images. It can help doctors see if prostate cancer cells are present in specific areas of the body.
Will this scan tell me if my cancer has spread?
While the main focus is on the area where your prostate used to be, the scan can also potentially detect other areas where the cancer might have spread, which would help doctors decide on the best treatment plan.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.